Detalhe da pesquisa
1.
Multifaceted effects of obesity on cancer immunotherapies: Bridging preclinical models and clinical data.
Semin Cancer Biol
; 95: 88-102, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37499846
2.
Increased efficacy of dual proinflammatory cytokine blockade on acute GVHD while maintaining GVT effects.
Blood
; 138(24): 2583-2588, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34424962
3.
Regulation of human and mouse bystander T cell activation responses by PD-1.
JCI Insight
; 8(18)2023 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37737264
4.
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial.
Nat Commun
; 14(1): 5332, 2023 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37658083
5.
Aging augments obesity-induced thymic involution and peripheral T cell exhaustion altering the "obesity paradox".
Front Immunol
; 13: 1012016, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36776393
6.
Transcriptome Analysis of Tumor-Infiltrating Lymphocytes Identifies NK Cell Gene Signatures Associated With Lymphocyte Infiltration and Survival in Soft Tissue Sarcomas.
Front Immunol
; 13: 893177, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35874727
7.
Mouse Preclinical Cancer Immunotherapy Modeling Involving Anti-PD-1 Therapies Reveals the Need to Use Mouse Reagents to Mirror Clinical Paradigms.
Cancers (Basel)
; 13(4)2021 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33578798
8.
Mechanisms by Which Obesity Promotes Acute Graft-Versus-Host Disease in Mice.
Front Immunol
; 12: 752484, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34707616
9.
Activation status dictates the function of unlicensed natural killer cells in mice and humans.
Blood Adv
; 5(20): 4219-4232, 2021 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496010
10.
PD-1 Blockade Reverses Obesity-Mediated T Cell Priming Impairment.
Front Immunol
; 11: 590568, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33193426
11.
Analysis of tumor-infiltrating NK and T cells highlights IL-15 stimulation and TIGIT blockade as a combination immunotherapy strategy for soft tissue sarcomas.
J Immunother Cancer
; 8(2)2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33158916